Related Experiment Video
Updated: Apr 23, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Exploring the complexity of pathway-drug relationships using latent Dirichlet allocation
Naruemon Pratanwanich1, Pietro Lio1
1Computer Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0FD, United Kingdom.
Abstract:
Analysis of cellular responses to diverse stimuli enables the exploration in the complexity of functional genomics. Typically, high-throughput microarray data allow us to identify genes that are differentially expressed under a phenomenon of interest. To extract the meanings from the long list of those differentially expressed genes, we present a new method "pathway-based LDA" to determine pathways/gene sets that are perturbed after exposure to different chemicals. In this study, a pathway is defined as a group of functionally related genes. Specifically, we have implemented a probabilistic Latent Dirichlet Allocation (LDA) model to learn drug-pathway-gene relations by taking known gene-pathway memberships as prior knowledge. We applied the pathway-based LDA model and 236 known pathways in order to determine pathway responsiveness to gene expression data of 1169 drugs. Our method yielded a better predictive performance on pathway responsiveness to drug treatments than the existing methods. Moreover, the pathway-based LDA also revealed genes contributing the most in each pre-defined pathway through a probabilistic distribution of genes. In achieving that, our method could provide a useful estimator of the pathway complexity of a genome.
Insights
We developed a new pathway-based Latent Dirichlet Allocation (LDA) method to analyze gene expression data. This approach effectively identifies perturbed biological pathways in response to drug treatments, improving upon existing methods.
Area of Science:
- Genomics
- Computational Biology
- Systems Biology
Background:
- High-throughput microarray data reveal differentially expressed genes under various conditions.
- Analyzing long lists of genes requires methods to extract biological meaning and identify functional relationships.
Purpose of the Study:
- To present a novel pathway-based Latent Dirichlet Allocation (LDA) method for analyzing gene expression data.
- To identify biological pathways perturbed by chemical treatments using gene expression profiles.
Main Methods:
- Implemented a probabilistic Latent Dirichlet Allocation (LDA) model incorporating known gene-pathway memberships as prior knowledge.
- Applied the pathway-based LDA model to gene expression data from 1169 drugs across 236 known pathways.
Main Results:
- The pathway-based LDA method demonstrated superior predictive performance in identifying pathway responsiveness to drug treatments compared to existing methods.
- The model revealed key genes contributing to each pathway through probabilistic gene distributions.
Conclusions:
- The developed pathway-based LDA method offers a robust approach for understanding genome-wide pathway complexity.
- This method provides a valuable tool for interpreting functional genomics data and drug responses.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Ligand-Gated Ion Channel Receptor: Gating Mechanism

